Showing results (1701-1710 of 2,133) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|November 1, 1988
Relative bioavailability of a controlled-release albuterol formulation for twice-daily useR S Sykes, M E Reese, M C Meyer, et al.Biopharmaceutics & Drug Disposition|June 20, 2020
Characterization of red ginseng-drug interaction by CYP3A activity increased in high dose administration in miceYounah Kim, Jung Jae Jo, Piljoung Cho, et al.Biopharmaceutics & Drug Disposition|June 21, 2020
Pharmacokinetic and pharmacodynamic modeling of the metastin/kisspeptin analog, TAK-448, for its anti-tumor efficacy in a rat xenograft modelAkifumi Kogame, Kaori Ishikawa, Joost DeJongh, et al.Biopharmaceutics & Drug Disposition|October 1, 1984
A model describing the disposition of phenytoin in isolated rat hepatocytesJ A Morais, J G WagnerBiopharmaceutics & Drug Disposition|October 1, 1984
The metabolic fate of 14C-oxaprotiline X HCl in man. III. Stereospecific dispositionW Dieterle, J W Faigle, W Küng, et al.Biopharmaceutics & Drug Disposition|July 1, 1984
Effects of penicillins on binding of phenytoin to plasma proteins in vitro and in vivoK Arimori, M Nakano, M Otagiri, et al.Biopharmaceutics & Drug Disposition|January 1, 1983
Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprololW Kirch, H Spahn, E E Ohnhaus, et al.Biopharmaceutics & Drug Disposition|January 1, 1983
Kinetics of cocaine in humans after intravenous and intranasal administrationJ I Javaid, M N Musa, M Fischman, et al.Biopharmaceutics & Drug Disposition|April 1, 1982
Bretylium pharmacokinetics and bioavailabilities in man with various doses and modes of administrationE R Garrett, J R Green, M BialerBiopharmaceutics & Drug Disposition|April 1, 1982
The assessment of fractional drug removal by extracorporeal dialysisC S LeePageof 214